Matrix metalloproteinase-8 as a potential drug target for the therapy of sepsis

Critical Care Medicine

Volumn 40, Issue 2, 2012, Pages 655-656

  Fink, Mitchell P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

collagenase; doxycycline; matrix metalloproteinase 8; sepsis

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; NEUTROPHIL COLLAGENASE; TUMOR NECROSIS FACTOR;

CLINICAL TRIAL (TOPIC); CYTOKINE RELEASE; DRUG TARGETING; EDITORIAL; ENZYME BLOOD LEVEL; ENZYME INHIBITION; GENE EXPRESSION; GENE MUTATION; HUMAN; MORTALITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPSIS; SEPTIC SHOCK; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; FEMALE; HUMANS; INFLAMMATION MEDIATORS; MALE; MATRIX METALLOPROTEINASE 8; MULTIPLE ORGAN FAILURE; SHOCK, SEPTIC;

EID: 84856189410     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31823b97d7     Document Type: Editorial

References (16)

1. Hadler-Olsen E, Fadnes B, Sylte I, et al.: Regulation of matrix metalloproteinase activity in health and disease. FEBS J 2011; 278:28-45
2. Solan PD, Dunsmore KE, Denenberg AG, et al.: A novel role for matrix metalloproteinase-8 in sepsis. Crit Care Med 2012; 40:379-387
3. Okamoto T, Akaike T, Nagano T, et al.: Activation of human neutrophil procollagenase by nitrogen dioxide and peroxynitrite: A novel mechanism for procollagenase activation involving nitric oxide. Arch Biochem Biophys 1997; 342:261-274
4. Knäuper V, Krämer S, Reinke H, et al.: Characterization and activation of procollagenase from human polymorphonuclear leucocytes. N-terminal sequence determination of the proenzyme and various proteolytically activated forms. Eur J Biochem 1990; 189: 295-300
5. Okamoto T, Akaike T, Suga M, et al.: Activation of human matrix metalloproteinases by various bacterial proteinases. J Biol Chem 1997; 272:6059-6066
6. Sepper R, Konttinen YT, Bue L, et al.: Potentiative effects of neutral proteinases in an inflamed lung: Relationship of neutrophil procollagenase (proMMP-8) to plasmin, cathepsin G and tryptase in bronchiectasis in vivo. Eur Respir J 1997; 10:2788-2793
7. Lauhio A, Hästbacka J, Pettilä V, et al.: Serum MMP-8, -9 and TIMP-1 in sepsis: High serum levels of MMP-8 and TIMP-1 are associated with fatal outcome in a multicentre, prospective cohort study. Hypothetical impact of tetracyclines. Pharmacol Res 2011; 64:590-594
8. Kaynar A, Rella JM, Bakan A, et al.: Matrix metalloproteinase (MMP)-8 is critical in a murine model of sepsis as well as in patients with community-acquired pneumonia (CAP)-associated sepsis. Am J Respir Crit Care Med 2010; 181:A1132
9. Hu J, Van den Steen PE, Dillen C, et al.: Targeting neutrophil collagenase/matrix metalloproteinase-8 and gelatinase B/matrix metalloproteinase-9 with a peptidomimetic inhibitor protects against endotoxin shock. Biochem Pharmacol 2005; 70:535-544
10. Van Lint P, Libert C: Matrix metalloproteinase- 8: Cleavage can be decisive. Cytokine Growth Factor Rev 2006; 17:217-223
11. Devel L, Czarny B, Beau F, et al.: Third generation of matrix metalloprotease inhibitors: Gain in selectivity by targeting the depth of the S1-cavity. Biochimie 2010; 92:1501-1508
12. Smith GN Jr, Mickler EA, Hasty KA, et al.: Specificity of inhibition of matrix metalloproteinase activity by doxycycline: Relationship to structure of the enzyme. Arthritis Rheum 1999; 42:1140-1146
13. Greenwald RA, Golub LM, Ramamurthy NS, et al.: In vitro sensitivity of the three mammalian collagenases to tetracycline inhibition: Relationship to bone and cartilage degradation. Bone 1998; 22:33-38
14. Smith GN Jr, Brandt KD, Hasty KA: Activation of recombinant human neutrophil procollagenase in the presence of doxycycline results in fragmentation of the enzyme and loss of enzyme activity. Arthritis Rheum 1996; 39:235-244
15. Basegmez C, Berber L, Yalcin F: Clinical and biochemical efficacy of minocycline in nonsurgical periodontal therapy: A randomized controlled pilot study. J Clin Pharmacol 2011; 51:915-922
16. Brandt KD, Mazzuca SA, Katz BP, et al.: Effects of doxycycline on progression of osteoarthritis: Results of a randomized, placebocontrolled, double-blind trial. Arthritis Rheum 2005; 52:2015-2025